Acute Coronary SyndromeHEART-SAUNCT05675267
Interest of the HEART Score for the Management of Patients With Chest Pain in Emergency Department
An observational study of Acute Coronary Syndrome, run by Université de Reims Champagne-Ardenne.
Trial summary
Chest pain is a frequent reason of consultation in emergency department. Emergency physician have to identify patients at high risk of Acute Coronary Syndrome from those presenting a lower risk. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acute Coronary Syndrome
- What is being tested?
- data collection
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- 10 Jan 2023to 1 Sep 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: patient with chest pain consulting in emergency department
Who may be able to join
- men and women Aged more than 18 Chest pain Consulting in emergency department Agreeing to participate to the study
Who cannot join
- aged less than 18 not agreeing to participate to the study
Trial locations and contacts
No sites are listed yet.
About this study
Chest pain is a frequent reason of consultation in emergency department. Emergency physician have to identify patients at high risk of Acute Coronary Syndrome from those presenting a lower risk.
Read the detailed description
The aim of the study is to study the interest of the HEART score for the management of patients with chest pain in emergency department
- Conditions
- Acute Coronary Syndrome
- Being tested
- data collection
- Keywords
- Acute Coronary Syndrome, chest pain, emergency department, HEART score
- Medical subject headings
- Acute Coronary Syndrome, Chest Pain, Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
data collectionOther
HEART score calculation
| Study group | Role | What they receive |
|---|---|---|
| patient with chest pain | Not described Receives: Other: data collection |
What is being measured
The primary outcome is the main question the study is designed to answer.
HEART score
Cardiovascular risk evaluated using HEART score. HEART score includes 5 items on history of chest pain, electrocardiogram, patient's age, cardiovascular risk factors and initial troponin. Each item is coded from 0 to 2 points, the overall score ranges from 0 to 10 points. Score between 0 and 3 indicated low risk of major adverse cardiovascular event, Score between 4 and 6 indicated moderate risk of major adverse cardiovascular event, Score between 7 and 10 indicated high risk of major adverse cardiovascular event
Measured: Day 0
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2023
- Study start10 Jan 2023 (estimated)
- Primary completion1 Jul 2023 (estimated)
- Study completion1 Sep 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Coronary SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Université de Reims Champagne-Ardenne
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05675267
- Sponsor's protocol ID
- 2022_RIPH_019_HEART-SAU
- Acronym
- HEART-SAU
- Status last verified
- Dec 2022
- First submitted
- 29 Dec 2022
- Last updated
- 9 Jan 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jan 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Interest of the HEART Score for the Management of Patients With Chest Pain in Emergency Department
- ClinicalTrials.gov ID
- NCT05675267
- Acronym / sponsor ID
- HEART-SAU / 2022_RIPH_019_HEART-SAU
- Conditions
- Acute Coronary Syndrome
- Keywords
- Acute Coronary Syndrome, chest pain, emergency department, HEART score
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Université de Reims Champagne-ArdenneUniversity, hospital or other
- Study start
- 10 Jan 2023 (estimated)
- Primary completion
- 1 Jul 2023 (estimated)
- Study completion
- 1 Sep 2023 (estimated)
- First posted
- 9 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Chest pain is a frequent reason of consultation in emergency department. Emergency physician have to identify patients at high risk of Acute Coronary Syndrome from those presenting a lower risk.
Detailed description
The aim of the study is to study the interest of the HEART score for the management of patients with chest pain in emergency department
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patient with chest pain | – | Other: data collection |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- patient with chest pain consulting in emergency department
Key inclusion criteria (1 listed)
- men and women Aged more than 18 Chest pain Consulting in emergency department Agreeing to participate to the study
Key exclusion criteria (1 listed)
- aged less than 18 not agreeing to participate to the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| data collectionHEART score calculation | Other | patient with chest pain |
Primary outcome
HEART score
Time frame: Day 0
Cardiovascular risk evaluated using HEART score. HEART score includes 5 items on history of chest pain, electrocardiogram, patient's age, cardiovascular risk factors and initial troponin. Each item is coded from 0 to 2 points, the overall score ranges from 0 to 10 points. Score between 0 and 3 indicated low risk of major adverse cardiovascular event, Score between 4 and 6 indicated moderate risk of major adverse cardiovascular event, Score between 7 and 10 indicated high risk of major adverse cardiovascular event
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jan 2023.
Related trials for Acute Coronary Syndrome
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
AI-Assisted Interpretation of Cardiac CT in the Emergency Department
Chest Pain, Acute Coronary Syndrome
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Coronary Syndrome, run by Université de Reims Champagne-Ardenne.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Pierre Willem, Dr (0326696048 ext. +33, pwillem@ch-chalonsenchampagne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
HEART score (time frame: Day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2023.